TKG Advisors’s Pfizer PFE Stock Holding History

TKG Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-75,447	Closed	-$2.11M	–	108
2024 Q2	$2.11M	Sell	75,447 -674	-0.9%	-$18.6K	1.15%	29
2024 Q1	$2.11M	Buy	76,121 +25,010	+49%	+$694K	1.18%	28
2023 Q4	$1.47M	Buy	51,111 +1,091	+2%	+$33K	0.88%	38
2023 Q3	$1.66M	Buy	50,020 +1,509	+3%	+$53.4K	1.11%	40
2023 Q2	$1.78M	Buy	+48,511	New	+$1.89M	1.16%	36

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

TKG Advisors's PFE Position: Q3 2024 in Review

TKG Advisors sold out of Pfizer (PFE) in Q3 2024, closing a stake of 75,447 shares — an estimated $2.11M sold.

TKG Advisors first reported a position in PFE in Q2 2023 and held it in 5 quarters. The position peaked at $2.11M in Q1 2024. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

TKG Advisors reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
TKG Advisors sold 75,447 Pfizer shares in Q3 2024, an estimated $2.11M.
TKG Advisors first reported a position in Pfizer in Q2 2023 and held it in 5 quarters.
TKG Advisors's Pfizer position peaked at $2.11M in Q1 2024.
2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on TKG Advisors's 13F filing for Q3 2024, filed 30 Oct 2024.